|
0
|
|
Safety of MVA-BN vaccine in health-care personnel in DR Congo: a prospective cohort study.
(linkinghub.elsevier.com)
|
Minhaj FS
…
McCollum AM
Lancet Infectious Diseases
2026-06-01
|
#vaccination
#immunogenicity
#safety
#cohort
#mpox
|
|
0
|
|
Immunogenicity and safety of MVA-BN vaccine administered 5 years after a two-dose primary series in DR Congo: a prospective cohort study.
(linkinghub.elsevier.com)
|
Priyamvada L
…
Townsend MB
Lancet Infectious Diseases
2026-06-01
|
#vaccination
#immunity
#immunogenicity
#safety
#mpox
|
|
0
|
|
Immunological mechanisms of mRNA vaccines for infectious diseases.
(nature.com)
|
Locci M
…
Pardi N
Nature
2026-06-01
|
#vaccination
#immunity
#rna
#immunogenicity
#infection
|
|
0
|
|
Safety and immunogenicity of a conjugate vaccine candidate against Salmonella enterica serovars Typhi and Paratyphi A in healthy adults in Europe: a phase 1 randomised controlled trial.
(linkinghub.elsevier.com)
|
De Coster I
…
Kumar Arora A
Lancet Infectious Diseases
2026-06-01
|
#vaccination
#clinical trial
#immunogenicity
#conjugate
#enteric fever
|
|
0
|
|
Efficacy of ETVAX, a vaccine against enterotoxigenic Escherichia coli-positive diarrhoea in Gambian children: a double-blind, randomised, placebo-controlled, phase 2b trial.
(linkinghub.elsevier.com)
|
Hossain MJ
…
Wierzba TF
Lancet Infectious Diseases
2026-06-01
|
#infection
#vaccination
#clinical trial
#immunogenicity
#diarrhea
|
|
0
|
|
Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex.
(nature.com)
|
Guenaga J
…
Wyatt RT
Nature
2026-06-01
|
#vaccination
#antibody
#immunogenicity
#hiv
|